Establishing proof-of-concept (POC) as quickly as possible is more important than ever.
Learn the latest techniques and study designs available to accelerate your path to proof-of-concept, including innovative ideas in combining SAD, MAD, preliminary interaction and POC studies with results that can cut your timelines by 50 percent.
Download the presentations now
|
Combined Phase I and IIa to Accelerate Proof-of-Concept
Graham Wood, PhD
President, Clinical Operations - Toronto & Miami
Cetero Research
|
 |
|
Fit-for-Purpose Biomarker Assay Development and Validation
Russ Weiner, PhD
Executive Director, Clinical Development Lab
Merck Research Laboratories
|
|
|
Advanced Population PK/PD Modeling and Analysis
Murray P Ducharme, PharmD, FCCP, FCP
Chief Science Officer
Cetero Research
|
